The announcement that Mass General Brigham has spun out AIwithCare to commercialize a retrieval-augmented screening platform signals something more consequential than another hospital-built analytics tool. Clinical trial enrollment remains one of the most stubborn constraints on biomedical progress, and it has stayed stubborn despite decades of site networks, CRO scale, and patient-facing marketing. When a health system treats prescreening as software infrastructure instead of coordinator labor, the bottleneck does not disappear. It relocates into governance, data quality, and accountability.

Artificial intelligence is rapidly embedding itself in core hospital functions—from diagnostics and decision support to patient documentation and claims processing. But as this technology shifts from pilot tools to operational infrastructure, healthcare leaders are entering a legal gray zone that few are structurally prepared to navigate.

Mount Sinai Health System’s announcement that it will deploy Microsoft Dragon Copilot marks yet another high-profile endorsement of AI-powered documentation tools. The integration of ambient voice capture and generative capabilities directly into clinical workflows signals a clear intent: free up clinicians’ time, reduce administrative load, and enhance patient-provider interaction.

As generative AI tools accelerate their reach across healthcare, a revealing paradox is emerging: physicians are leading the charge in experimentation, but the systems meant to support them remain unprepared.

Microsoft’s expansion of its Dragon Copilot AI assistant into nursing workflows marks a notable shift in the trajectory of ambient clinical technology. What began as a physician-facing tool designed to streamline documentation is evolving into a platform with enterprise-wide ambitions, encompassing revenue cycle operations, third-party AI integration, and now the day-to-day responsibilities of frontline nurses.

As artificial intelligence continues its rapid integration into clinical workflows, a looming liability vacuum threatens to destabilize trust, governance, and accountability in patient care. While AI tools promise greater efficiency, diagnostic power, and operational agility, legal experts are raising alarms about the absence of clearly defined fault lines when outcomes go wrong.

Artificial intelligence is already shaping how care is delivered, how health systems operate, and how patients access services. But the rapid pace of AI adoption is exposing a foundational gap: health care lacks the infrastructure, incentives, and oversight mechanisms to evaluate whether these tools are actually improving health outcomes.

A legal feud between Doximity and OpenEvidence has pulled into sharp relief the growing pains of healthcare artificial intelligence, particularly where innovation meets intellectual property. At the center of the case are allegations that Doximity used fake physician accounts to “prompt hack” OpenEvidence’s AI platform, extracting proprietary inputs and underlying logic. Doximity denies the claims and has countersued for defamation.